Samsung P/E premium over SK Hynix set to rise on HBM share gains (SSNLF:OTCMKTS)
Samsungâs P/E premium vs SK Hynix may rebound as it regains HBM market share, UBS says.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Samsungâs P/E premium vs SK Hynix may rebound as it regains HBM market share, UBS says.
Samsung P/E premium over SK Hynix set to rise on HBM share gains (SSNLF:OTCMKTS) | Seeking Alpha
Victor Golmer/iStock Editorial via Getty Images
Samsung
âs (
SSNLF
) price-to-earnings premium over SK Hynix (
SKHY
), which was near its lowest level in two years, is poised to rise as the company regains lost HBM market share against its rival.
UBS models Samsungâs (
SSNLF
) share of
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Gencor GAAP EPS of $0.39, revenue of $33.81M
Gencor press release (GENC): Q3 GAAP EPS of $0.39. Revenue of $33.81M (+25.3% Y/Y). At June 30, 2026, the company had $164.2 million of cash and cash equivalents
PBoC halts short-term liquidity injections for first time since June
The Peopleâs Bank of China (PBoC) conducted zero seven-day reverse repos in its open market operations on Tuesday, marking the first time since June that the central bank injected no liquidity via the short-term facility.
IHeartMedia Reaffirms $800M EBITDA Target, Q3 Guidance of $180M-$220M Highlights Ad Market Resilience
IHeartMedia maintains its full-year adjusted EBITDA target of $800 million and free cash flow of $200 million, with Q3 guidance of $180-$220 million. Political advertising supports broadcast, while digital growth slows and cost control becomes key.
Tactile Medical projects $360M-$366M 2026 revenue as airway clearance ordering normalizes in Q4 (NASDAQ:TCMD)
TCMD Q2 2026 earnings call recap: raised revenue guidance to $360â$366M, lymphedema strength, AffloVest inventory reset, Medicare prior auth impactâread...